RESEARCH PAPER
Preliminary investigation evaluating college students’ willingness and need to take pre-exposure prophylaxis (PrEP) for HIV
More details
Hide details
Submission date: 2017-08-10
Final revision date: 2017-11-14
Acceptance date: 2018-01-10
Publication date: 2018-05-21
HIV & AIDS Review 2018;17(2):98-102
KEYWORDS
TOPICS
ABSTRACT
Pre-exposure prophylaxis (PrEP) is a highly effective pharmacological approach to HIV prevention. This study sought to evaluate the need and willingness of African American college students to utilize PrEP. We evaluated students’ perceived HIV risk, beliefs about medication, sexual risk behaviors, and need for PrEP. The sample consisted of 147 participants (Mage = 21.6 years, SDage = 4.8), and 57.7% were female. Most of the sample had been sexually active in the past. Participants were willing to initiate PrEP if they knew it would lower their chance of contracting HIV (88.2%), knew their partner was HIV positive (85.4%), or thought they were at high-risk for HIV infection (87.9%). Additionally, there was a strong positive relationship between willingness to initiate PrEP and beliefs about medicine (r = 0.217, p < 0.05). These findings have relevant implications that will aid in the promotion of PrEP uptake and initiation among at-risk college students.
REFERENCES (21)
1.
Prejean J, Song R, Hernandez A, et al.; HIV Incidence Surveillance Group. Estimated HIV incidence in the United States, 2006-2009. PLoS One 2011; 6: e17502.
2.
Centers for Disease Control and Prevention (2015). Diagnoses of HIV Infection in the United States and Dependent Areas, 2013. Retrieved from:
http://www.cdc.gov/hiv/library....
3.
UNAIDS report on the global AIDS epidemic. WHO Library Cataloguing-in-Publication Data, Geneva 2013.
4.
Rosenberg ES, Grey JA, Sanchez TH, et al. Rates of Prevalent HIV Infection, Prevalent Diagnoses, and New Diagnoses Among Men Who Have Sex with Men in US States, Metropolitan Statistical Areas, and Counties, 2012-2013. JMIR Public Health Surveill 2016; 2: e22.
5.
Underhill K, Morrow KM, Colleran C, et al. Explaining the Efficacy of Pre-Exposure Prophylaxis (PrEP) for HIV Prevention: A Qualitative Study of Message Framing and Messaging Preferences among US Men Who Have Sex with Men. AIDS Behav 2016; 20: 1514-1526.
6.
Cohen SE, Vittinghoff E, Bacon O, et al. High interest in preexposure prophylaxis among men who have sex with men at risk for HIV infection: baseline data from the US PrEP demonstration project. J Acquir Immune Defic Syndr 2015; 68: 439-448.
7.
Oldenburg CE, Perez-Brumer AG, Hatzenbuehler ML, et al. State-level structural sexual stigma and HIV prevention in a national online sample of HIV-uninfected MSM in the United States. AIDS 2015; 29: 837-845.
8.
Van der Elst EM, Mbogua J, Operario D, et al. High acceptability of HIV pre-exposure prophylaxis but challenges in adherence and use: qualitative insights from a phase I trial of intermittent and daily PrEP in at-risk populations in Kenya. AIDS Behav 2013; 17: 2162-2172.
9.
Bauermeister JA, Meanley S, Pingel E, et al. PrEP awareness and perceived barriers among single young men who have sex with men. Curr HIV Res 2013; 11: 520-527.
10.
Golub SA, Gamarel KE, Rendina HJ, et al. From efficacy to effectiveness: facilitators and barriers to PrEP acceptability and motivations for adherence among MSM and transgender women in New York City. AIDS Patient Care STDS 2013; 27: 248-254.
11.
Krakower DS, Mimiaga MJ, Rosenberger JG, et al. Limited Awareness and Low Immediate Uptake of Pre-Exposure Prophylaxis among Men Who Have Sex with Men Using an Internet Social Networking Site. PLoS One 2012; 7: e33119.
12.
Rucinski KB, Mensah NP, Sepkowitz KA, et al. Knowledge and use of pre-exposure prophylaxis among an online sample of young men who have sex with men in New York City. AIDS Behav 2013; 17: 2180-2184.
13.
Whiteside YO, Harris T, Scanlon C, et al. Self-perceived risk of HIV infection and attitudes about preexposure prophylaxis among sexually transmitted disease clinic attendees in South Carolina. AIDS Patient Care STDS 2011; 25: 365-370.
14.
Young I, McDaid L. How acceptable are antiretrovirals for the prevention of sexually transmitted HIV?: A review of research on the acceptability of oral pre-exposure prophylaxis and treatment as prevention. AIDS Behav 2014; 18: 195-216.
15.
Horne R, Graupner L, Frost S, et al. Medicine in a multi-cultural society: the effect of cultural background on beliefs about medications. Soc Sci Med 2004; 59: 1307-1313.
16.
Napper LE, Fisher DG, Reynolds GL. Development of the perceived risk of HIV scale. AIDS Behav 2012; 16: 1075-1083.
17.
PrEP a new option for women for safer loving. A Publication for Women Who Sleep with Men. Project Inform, San Francisco 2014.
18.
Smith DK, Toledo L, Smith DJ, et al. Attitudes and program preferences of African-American urban young adults about pre-exposure prophylaxis (PrEP). AIDS Educ Prev 2012; 24: 408-421.
19.
Mustanski B, Johnson AK, Garofalo R, et al. Perceived likelihood of using HIV pre-exposure prophylaxis medications among young men who have sex with men. AIDS Behav 2013; 17: 2173-2179.
20.
Galea JT, Kinsler JJ, Salazar X, et al. Acceptability of pre-exposure prophylaxis as an HIV prevention strategy: barriers and facilitators to pre-exposure prophylaxis uptake among at-risk Peruvian populations. Int J STD AIDS 2011; 22: 256-262.